FDA NDC Directory · JSON-LD · Markdown

Kaletra

NDC 0074-3956 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nameLopinavir and Ritonavir
Labeler / ManufacturerAbbVie Inc.
Marketing categoryNew Drug Application (innovator) · App NDA021251
Dosage form / routeSOLUTION · ORAL
Active ingredientsLOPINAVIR (80 mg/mL)
RITONAVIR (20 mg/mL)
Marketing started20100618
Package count1

External sources

Source: openFDA. Public-domain (CC0).